KKR handed equity boost from Boots stake sale

US buyout firm receives the lion's share of its equity investment in Alliance Boots back after the sale of a 45% stake in the UK-based chemist chain

Kohlberg Kravis Roberts has received the lion's share of its equity investment in Alliance Boots back after the sale of a 45% stake in the UK-based chemist chain to US drug store Walgreen for $6.7bn.

The US buyout firm, which invested £1.2bn in the company in 2007 - in what remains Europe's largest-ever leveraged buyout at £11.1bn - has received £1.2bn back in the deal, announced this morning. Walgreen will also have the option to buy the rest of the shares in the future.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump